These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids. Shen J, Pinkus GS, Deshpande V, Cibas ES. Am J Clin Pathol; 2009 Apr; 131(4):516-23. PubMed ID: 19289587 [Abstract] [Full Text] [Related]
12. The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion. Dejmek A, Hjerpe A. Diagn Cytopathol; 2005 Mar; 32(3):160-6. PubMed ID: 15690331 [Abstract] [Full Text] [Related]
14. The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant. Aerts JG, Delahaye M, van der Kwast TH, Davidson B, Hoogsteden HC, van Meerbeeck JP. Diagn Cytopathol; 2006 Aug; 34(8):523-7. PubMed ID: 16850492 [Abstract] [Full Text] [Related]
16. Differential diagnosis of reactive mesothelial cells and malignant mesothelioma cells using the cell proliferation markers minichromosome maintenance protein 7, geminin, topoisomerase II alpha and Ki-67. Kimura F, Okayasu I, Kakinuma H, Satoh Y, Kuwao S, Saegusa M, Watanabe J. Acta Cytol; 2013 Aug; 57(4):384-90. PubMed ID: 23860238 [Abstract] [Full Text] [Related]
17. Well-differentiated papillary mesothelioma with invasion to the chest wall. Torii I, Hashimoto M, Terada T, Kondo N, Fushimi H, Shimazu K, Takeda S, Takuwa T, Okumura Y, Sato A, Yamamoto T, Fukuoka K, Tanaka F, Nishigami T, Nakano T, Hasegawa S, Tsujimura T. Lung Cancer; 2010 Feb; 67(2):244-7. PubMed ID: 19880210 [Abstract] [Full Text] [Related]